High-mobility group box 1 protein plasma concentrations during septic shock

被引:153
作者
Gibot, Sebastien
Massin, Frederic
Cravoisy, Aurelie
Barraud, Damien
Nace, Lionel
Levy, Brune
Bollaert, Pierre-Edouard
机构
[1] Hop Cent, Serv Reanimat Med, F-54000 Nancy, France
[2] Univ Nancy 1, Grp Choc, Contrat AVENIR INSERM, U684,Fac Med, F-54500 Vandoeuvre Les Nancy, France
[3] Univ Nancy 1, Immunol Lab, Fac Med, F-54000 Nancy, France
关键词
septic shock; HMGB1; prognosis;
D O I
10.1007/s00134-007-0691-2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To investigate plasma high- mobility group box 1 protein (HMGB1) concentration and its relationship with organ dysfunction and outcome in septic shock patients. Design and setting: Prospective, noninterventional study. Medical adult intensive care unit at a university hospital in France. Patients: 42 critically ill patients with septic shock. Methods: Arterial blood was drawn within 12 h of admission for the measurement of plasma HMGB1 concentration by ELISA. Repeated sampling was performed on days 3, 7, and 14. Results: Median HMGB1 concentration was 4.4 ng/ml (IQR 1.2-12.5) at admission, with no difference between survivors and nonsurvivors. A positive correlation was observed between HMGB1 and SOFA score and lactate, and procalcitonin concentrations. There was a progressive but statistically nonsignificant decline in HMGB1 concentration among the survivors, while nonsurvivors showed an increase in HMGB1 level between days 1 and 3. SOFA score and lactate and procalcitonin concentrations did not vary significantly between days 1 and 3. When measured on day 3, HMGB1 discriminated survivors from nonsurvivors with 66% sensitivity and 67% specificity, and concentration greater than 4 ng/ml was associated with an odds ratio of death of 5.5 (95% CI 1.3-23.6).
引用
收藏
页码:1347 / 1353
页数:7
相关论文
共 31 条
  • [1] BUSTIN M, 1978, J BIOL CHEM, V253, P1694
  • [2] Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis
    Chen, GQ
    Li, JH
    Qiang, XL
    Czura, CJ
    Ochani, M
    Ochani, K
    Ulloa, L
    Yang, H
    Tracey, KJ
    Wang, P
    Sama, AE
    Wang, HC
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (04) : 623 - 627
  • [3] Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms
    Chen, GQ
    Li, JH
    Ochani, M
    Rendon-Mitchell, B
    Qiang, XL
    Susarla, S
    Ulloa, L
    Yang, H
    Fan, SJ
    Goyert, SM
    Wang, P
    Tracey, KJ
    Sama, AE
    Wang, HC
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (05) : 994 - 1001
  • [5] High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis:: a prospective study
    Gaini, Shahin
    Pedersen, Svend Stenvang
    Koldkjær, Ole Græsboll
    Pedersen, Court
    Moller, Holger Jon
    [J]. CRITICAL CARE, 2007, 11 (02):
  • [6] Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation
    Hatada, T
    Wada, H
    Nobori, T
    Okabayashi, K
    Maruyama, K
    Abe, Y
    Uemoto, S
    Yamada, S
    Maruyama, I
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (05) : 975 - 979
  • [7] THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE) IS A CELLULAR-BINDING SITE FOR AMPHOTERIN - MEDIATION OF NEURITE OUTGROWTH AND COEXPRESSION OF RAGE AND AMPHOTERIN IN THE DEVELOPING NERVOUS-SYSTEM
    HORI, O
    BRETT, J
    SLATTERY, T
    CAO, R
    ZHANG, JH
    CHEN, JX
    NAGASHIMA, M
    LUNDH, ER
    VIJAY, S
    NITECKI, D
    MORSER, J
    STERN, D
    SCHMIDT, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) : 25752 - 25761
  • [8] JANEWAY CA, 1989, COLD SH Q B, V54, P1
  • [9] Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions - Role of activated macrophages and cytokines
    Kalinina, N
    Agrotis, A
    Antropova, Y
    DiVitto, G
    Kanellakis, P
    Kostolias, G
    Ilyinskaya, O
    Tararak, E
    Bobik, A
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (12) : 2320 - 2325
  • [10] Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305